Who is Nathan? Nathan was a beautiful little boy who loved Elmo, playing in the pool and being with his mommy and daddy. Born on Tuesday, March 24, 2009. Weighing 7 pounds 6 ounces and 19 ½ inches long, Nathan was perfect. In the beginning, like many parents we were back and forth to the pediatrician’s office for what was thought to be reflux. On May 5, 2009, our lives would forever change when Nathan was diagnosed with stage 4 Neuroblastoma at 6 weeks old.
Instead of watching our son reach his milestones our days were overcome with chemotherapy and surgery. After 6 rounds of chemotherapy in November of 2009, Nathan had reached NED, no evidence of disease. We would then begin traveling to Memorial Sloan Kettering in NYC for a clinical trial used for preventative treatment. In January 2010 the cancer had spread and Nathan would require more surgery, chemotherapy, and radiation to continue to fight this disease. The next several months consisted of multiple hospitalizations at Hasbro Children’s Hospital and Memorial Sloan Kettering. When Nathan wasn’t admitted he was going to treatments at the Tomorrow Fund Clinic at Hasbro.
Normalcy for our family was being in the hospital. As a result of the constant support from our family, friends and the community we were always able to be by our precious baby’s bedside. He was never alone. Words will never truly express what that meant to us. In the time we had we were able to enjoy those little moments and be amazed by Nathan’s resilience and strength even when his body was so weak.
The Nathan’s Angels Memorial Foundation was established in order to honor the memory of our son. Nathan Joseph Soares earned his angel wings on September 17, 2010. We will never forget his beautiful smile and the love Nathan was able to share with us. Our mission is to help other families whose child has been stricken with a critical cancer diagnosis to help offset some of the financial burden that goes along with this disease. With your generous support we can help families be by their child’s side.